glp-1 agonist and heart failure Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes Mechanisms of GLP-1 Receptor Agonists
Description
In vitro and in vivo research has demonstrated that Liraglutide and Exenatide show anti-liver cancer effects by attenuating inflammation and inhibiting the proliferation of liver cancer cells [43]

Activation of gastrointestinal ileal brake response with dietary slowly digestible carbohydrates, with no observed effect on subjective appetite, in an acute randomized, double-blind, crossover trial
doi: 10.1210/jc.2003-031403 [DOI] [PubMed] [Google Scholar] 38.Muskiet MH Tonneijck L Smits MM, et al

These medications have shown promising results in helping patients improve glycemic control and achieve weight loss, making them a popular treatment option ( 5 9 )

This work was also supported by the National Key Research and Development Program of China (2018YFA0507001, 2018YFA0507000, 2018YFA0508100), the National Natural Science Foundation of China grants 31770898 (G.S.), 31900895 (L.Y.) and 81872915 (M.-W.W.), the National Science and Technology Major Project Key New Drug Creation and Manufacturing Program of China (2018ZX09735-001) and China Postdoctoral Science Foundation (2017M622365)

Holst JJ, Knop FK, Vilsbll T, Krarup T, Madsbad S
